Bright Minds Biosciences Inc (DRUG) Stock Price, Quote & News

Company Profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develo...

Industry: Biotechnology

Sector: Healthcare

Phone: 647 865 8622

Website: brightmindsbio.com

Address:

19 Vestry Street, New York, United States

Stock__Hunter Feb. 23 at 1:13 AM

$NCI MR. A =2/5/10/20 then 50 baggers. So far you at 10 and next level @ 20.. then $BNAI $DRUG. Bk and we'll open your peeps

0 · Reply

ironic_username Feb. 18 at 8:52 PM

$SNSE the smarter shorts will look to cover before end of day because no one wants to wake up to something that opens at double or triple where it is now. When that happens, the cascade will start and we’ll be in the 50’s in no time. This has $SMX and $DRUG written all over it. The fact that they can’t sell this down further tells you all you need to know. HODL

0 · Reply

Digitalization2026 Feb. 17 at 11:55 PM

🚨 $CETX – Remember This Don’t listen to fake bulls or bears 🛑. Fundamentals tell the real story: Q1 FY26 rev +17% to $16.1M, Industrial +28%, cash +312% to $20.5M vs tiny ~$12.6M market cap while TTM revenue $76M — so cash on hand ($20M) > market cap and annual sales far exceed valuation 😳 Invocon & Richland acquisitions complete, expanding aerospace/defense + industrial footprint 🚀. We’re early stage, building recurring revenue like larger peers. 📅 Catalysts: Q2 earnings w/full acquisition impact, backlog & contract updates, margins recovery, cost actions, tech breakouts 📈. Shorts & high borrow costs 📉 — fundamentals always win ⚡. We’ve seen stocks 100–2000% moves in a day when the narrative shifts 💎 📈 Spec Targets: $3–$5 early, $8–$12 momentum, $15–$25 extended, $30+ aggressive. $LMT $AUUD $RIME $DRUG

0 · Reply

firetypecracker Feb. 17 at 8:25 PM

$HELP NEWS TODAY: Analysts Offer Insights on Healthcare Company: Helus Pharma ($HELP) (pronounced: Heal us) There’s a lot to be optimistic about in the Healthcare sector, as 2 analysts just weighed in on Cybin, aka Helus Pharma. In a report issued on February 13, 2026, Sumant Kulkarni from Canaccord Genuity reiterated a Buy rating on Helus, with a price target of $45.00. According to Tipranks, Kulkarni is a 4-star analyst with an average return of 6.4% and a 43.5% success rate. Kulkarni covers the Healthcare sector, focusing on stocks such as ACADIA Pharmaceuticals, Zevra Therapeutics, and Stoke Therapeutics. Currently, the analyst consensus on Helus is a STRONG BUY with an average price target of $40.00, a 525.0% upside from current levels. In a report issued on February 1, Jefferies also initiated coverage with a BUY rating on the stock with a $22.00 price target. $CMPS $VKTX $ATAI $DRUG https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cybin-help-and-ocular-therapeutix-ocul-blurbs-news

0 · Reply

TinyTiger19 Feb. 17 at 7:02 PM

$DRUG $RAPP $CRCL $OSW ^•*^

0 · Reply

OfficialStocktwitsUser Feb. 17 at 4:24 PM

$DRUG RSI: 45.06, MACD: -1.3104 Vol: 4.79, MA20: 80.29, MA50: 82.94 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

VegasG Feb. 17 at 2:09 PM

$IBRX Is this the second coming of $DRUG?

0 · Reply

firetypecracker Feb. 16 at 3:04 PM

$HELP Stop the day-trading. Buy and hold for huge gains, not pennies... $ATAI $CMPS $VKTX $DRUG

0 · Reply

addicted2pennies Feb. 16 at 12:16 AM

$RIME are we looking at the next $DRUG

1 · Reply

VegasG Feb. 14 at 10:22 AM

I suspect you are correct. I’d Love it if it blasted off to Alpha Centuri the way $DRUG did a couple years ago. That was one in a million! Went from $1.10 to over $60 a share in ONE FREAKING DAY!!!! Bright Minds was the company name. THATS WHAT CAN HAPPEN when the bears don’t run wild and the sharks don’t steal it and lock it down. ALL WE ARE SAYING IS GIVE RETAIL A CHANCE 🙏🙏🙏

1 · Reply

BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News

Fri, 09 Jan 2026 11:56:00 -0500 - 6 weeks ago

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

2026-01-08T07:57:10.000Z - 6 weeks ago

Bright Minds Biosciences (DRUG) Prices $175M Public Offering

Wed, 07 Jan 2026 21:33:00 -0500 - 6 weeks ago

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

Wed, 07 Jan 2026 15:00:21 -0500 - 6 weeks ago

Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating

2026-01-07T13:05:22.000Z - 6 weeks ago

Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

2026-01-06T21:04:47.000Z - 6 weeks ago

Bright Minds Biosciences launches $100 million public offering

Tue, 06 Jan 2026 16:00:00 -0500 - 6 weeks ago

Bright Minds Biosciences Announces Launch of US$100 Million Public Offering

2026-01-06T18:31:59.000Z - 6 weeks ago

BTIG Raises Price Target for Bright Minds Biosciences (DRUG) to $147 | DRUG Stock News

2026-01-06T18:00:09.000Z - 6 weeks ago

Bright Minds Biosciences Inc BMB-101 Topline data announcement Transcript

Tue, 06 Jan 2026 11:52:33 -0500 - 6 weeks ago

New Bright Minds Epilepsy Drug Cuts Seizures, Lifts Stock On Tuesday

2026-01-06T15:07:53.000Z - 6 weeks ago

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

2026-01-06T13:00:04.000Z - 6 weeks ago

Bright Minds Biosciences (DRUG) Surges on Successful Trial Results

2026-01-06T12:43:27.000Z - 6 weeks ago

Bright Minds gains on mid-stage trial win for lead asset

Tue, 06 Jan 2026 07:16:00 -0500 - 6 weeks ago

Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

2026-01-06T09:04:44.000Z - 6 weeks ago

Bright Minds To Unveil Topline Results For BMB-101 Phase 2 Trial In Absence Seizures And DEE

Mon, 05 Jan 2026 16:30:00 -0500 - 7 weeks ago

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

2026-01-02T13:30:17.000Z - 7 weeks ago

Bright Minds Biosciences (DRUG) Maintains Buy Rating with $80 Price Target | DRUG Stock News

2025-12-30T16:00:54.000Z - 7 weeks ago

Bright Minds Biosciences (DRUG) Sees Stable Analyst Rating Today | DRUG Stock News

Tue, 25 Nov 2025 16:30:00 -0500 - 3 months ago

Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

2025-11-25T14:55:03.000Z - 3 months ago

Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 36.27%: Read This Before Placing a Bet

2025-11-17T22:29:36.000Z - 3 months ago

Why Bright Minds Biosciences Stock Topped the Market on Monday

Mon, 17 Nov 2025 06:50:00 -0500 - 3 months ago

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

2025-11-15T01:53:30.000Z - 3 months ago

Sio Capital Management, LLC Reduces Stake in Bright Minds Biosciences Inc

Thu, 06 Nov 2025 06:30:00 -0500 - 3 months ago

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

2025-10-15T12:50:03.000Z - 4 months ago

Bright Minds Biosciences Inc. (DRUG) is on the Move, Here's Why the Trend Could be Sustainable

2025-09-18T13:55:01.000Z - 5 months ago

Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade

2025-09-15T12:33:59.000Z - 5 months ago

Bright Minds Biosciences (DRUG) Maintains 'Buy' Rating with $85 Price Target | DRUG Stock News

2025-09-08T17:54:11.000Z - 6 months ago

Large Patient Population Is Key Driver For Bright Minds' Growth

2025-09-05T10:56:42.000Z - 6 months ago

Bright Minds Biosciences (DRUG) Launches $100 Million ATM Offering

2025-09-05T00:00:00.000Z - 6 months ago

BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING

Tue, 20 May 2025 08:00:00 -0400 - 9 months ago

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025

Wed, 07 May 2025 16:45:18 -0400 - 10 months ago

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

2025-05-07T20:45:18.000Z - 10 months ago

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

Mon, 28 Apr 2025 08:00:00 -0400 - 10 months ago

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

2025-04-16T16:09:11.000Z - 11 months ago

Bright Minds Biosciences: A Buy With A Major Catalyst In Q2 2025

2025-02-15T04:14:47.000Z - 1 year ago

COMMODORE CAPITAL LP's Strategic Acquisition in Bright Minds Biosciences Inc

2025-02-10T20:16:59.000Z - 1 year ago

Sio Capital Management, LLC Acquires Significant Stake in Bright Minds Biosciences Inc

2025-02-07T18:23:53.000Z - 1 year ago

JANUS HENDERSON GROUP PLC Acquires Shares in Bright Minds Biosciences Inc

2025-01-26T11:32:26.000Z - 1 year ago

Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101

2025-01-07T12:02:11.000Z - 1 year ago

Bright Minds Biosciences names Stephen Collins as chief medical officer

Tue, 07 Jan 2025 06:50:00 -0500 - 1 year ago

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer

Wed, 13 Nov 2024 12:59:00 -0500 - 1 year ago

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

Mon, 04 Nov 2024 14:41:00 -0500 - 1 year ago

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

2024-11-04T16:05:09.000Z - 1 year ago

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?

2024-10-30T05:07:00.000Z - 1 year ago

Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential

Mon, 28 Oct 2024 08:21:00 -0400 - 1 year ago

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

2024-10-23T01:06:51.000Z - 1 year ago

Cormorant Asset Management's Strategic Acquisition of Bright Minds Biosciences Shares

2024-10-21T14:33:37.000Z - 1 year ago

What's Going On With Bright Minds Biosciences Stock?

Mon, 21 Oct 2024 08:30:00 -0400 - 1 year ago

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

Oct 18, 2024, 6:50 AM EDT - 1 year ago

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

Oct 16, 2024, 10:45 AM EDT - 1 year ago

Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

Oct 16, 2024, 5:57 AM EDT - 1 year ago

Biotech stock tumbles after unexplained 1,446% gain

Oct 15, 2024, 9:09 PM EDT - 1 year ago

Bright Minds is Unaware of Any Material Changes

Oct 3, 2024, 9:00 AM EDT - 1 year ago

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Sep 12, 2024, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Aug 8, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 20, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 12, 2023, 10:33 AM EDT - 2 years ago

CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)

Jul 11, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Announces Effective Date of Share Consolidation

Jun 22, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Announces Proposed Share Consolidation

Apr 19, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Apr 10, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

Feb 27, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Feb 17, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Executive Director Appointment

Feb 8, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Jan 27, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Jan 9, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Resignation of Board Member

Dec 2, 2022, 7:07 PM EST - 3 years ago

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Nov 28, 2022, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Brokered Private Placement

Nov 23, 2022, 11:35 AM EST - 3 years ago

Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D.

Sep 7, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Aug 31, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

Aug 30, 2022, 3:35 PM EDT - 3 years ago

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Aug 23, 2022, 9:07 PM EDT - 3 years ago

Bright Minds Announces Pricing of Overnight Marketed Offering of Units

Aug 22, 2022, 7:05 PM EDT - 3 years ago

Bright Minds Announces Overnight Marketed Offering of Units

Aug 18, 2022, 3:34 PM EDT - 3 years ago

Bright Minds Biosciences Comments on Recent Trading Activity

Jun 27, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

May 12, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome

Stock__Hunter Feb. 23 at 1:13 AM

$NCI MR. A =2/5/10/20 then 50 baggers. So far you at 10 and next level @ 20.. then $BNAI $DRUG. Bk and we'll open your peeps

0 · Reply

ironic_username Feb. 18 at 8:52 PM

0 · Reply

Digitalization2026 Feb. 17 at 11:55 PM

0 · Reply

firetypecracker Feb. 17 at 8:25 PM

0 · Reply

TinyTiger19 Feb. 17 at 7:02 PM

$DRUG $RAPP $CRCL $OSW ^•*^

0 · Reply

OfficialStocktwitsUser Feb. 17 at 4:24 PM

0 · Reply

VegasG Feb. 17 at 2:09 PM

$IBRX Is this the second coming of $DRUG?

0 · Reply

firetypecracker Feb. 16 at 3:04 PM

$HELP Stop the day-trading. Buy and hold for huge gains, not pennies... $ATAI $CMPS $VKTX $DRUG

0 · Reply

addicted2pennies Feb. 16 at 12:16 AM

$RIME are we looking at the next $DRUG

1 · Reply

VegasG Feb. 14 at 10:22 AM

1 · Reply

Stock__Hunter Feb. 13 at 4:41 PM

$HURA market likes bio/ $DRUG

0 · Reply

turk123 Feb. 13 at 1:15 AM

$GLTO moving like $DRUG did when it went from $1 to $160

0 · Reply

Trader1141 Feb. 12 at 1:12 PM

$QNCX $ELPW $DRUG $SMX Loks like $JDZG flexing!! 😎

0 · Reply

Aamadmi Feb. 11 at 12:09 AM

$QNCX Repeat $DRUG like run to $60 QNCX. Those longs will be rich.....Checking pattern forming. But who knows where it will end up. GL

0 · Reply

honestrick Feb. 10 at 7:49 PM

$XRTX Volume coming in heavy for this stock ,any suggestions? $NVDA $DRUG $AAPL

0 · Reply

twentyp Feb. 9 at 11:16 PM

$BMNR $DRUG $OCG $SBET $SMX whatapp loser we lost 70% because of your shitty stock

1 · Reply

skyrockets_Inc Feb. 6 at 8:49 PM

$CYCN cont. from post below. $DRUG another example that just so happened to be at the EXACT same price as us $1.08/share before PIPE announcement and it went 80x ! Not saying this is what is going to happen here...but one thing we know is we definitely need to raise 50M based on company statements...so how else will that be done? Either PIPE or Tisento Sale?

0 · Reply

tupelo3 Feb. 6 at 7:19 PM

$DRUG How come my ochat history on $DRUG only goes back to 1/16/26?

0 · Reply

Digitalization2026 Feb. 6 at 6:27 PM

$CETX $OPEN $SMX $DRUG $NOC 🚀 $CETX — Pushing Toward $1.75 Break Cemtrex ($CETX) is moving toward a clean $1.75 breakout ⚡. Volume is still low, thin tape + low float means small buys can push price fast. Could be the ultimate short squeeze if momentum hits 👀. 📊 Why This Matters: • Vicon Security 🛡️ — Protects schools, hospitals & businesses • AIS Industrial Services 🏭 — Growing backlog & recurring revenue • Invocon Aerospace & Defense ✈️🛡️ — Mission-critical engineering, prime contracts 📅 Upcoming Catalysts: • Earnings Feb 13, 2026 (pre-market) • Richland & Invocon integration updates • New contracts or industrial/defense expansions • Any unexpected news could spike momentum 📈 Speculative Targets: $5–$8 → $10–$15+ → $20+ if execution continues. ⚠️ Reality Check: High volatility expected. Know what you own. Ignore fake bulls & bears. Not financial advice.

0 · Reply

TheRealStockRocket Feb. 6 at 3:37 PM

$LEXX $LEXX will be my biggest gainer ever and Im very confident of this...and thats over 25+ years in trading stocks and doing the extensive research. All the DD is there and matches if not better than some of the biggest $1 to $50-$100 biotech companies we have seen in the last few years. $DRUG comes to mind and Emisphere Technologies bought by Novo nordisk. Right now the stock is being manipulated and loaded. There is no diution (fully funded as per filing in 8k for entire 2026), there is no offering( just closed one in november for 1.41 a share, and there are no warrants exercisable....The "MTA" pharma company in the filings is one of the big 5 that well all can agree on...And there is so many other uses their technology can benefit all the major disease drugs on the market and lets not forget CBD tech and platform to.

3 · Reply

Digitalization2026 Feb. 5 at 5:43 PM

$BTOG $XTKG $BNAI $SMX $DRUG 🚨 $BTOG – Back Under $2.75, Setup Still Hot Bit Origin ($BTOG) slipped below $2.75, but ultra-low float (~1.5M shares) and thin tape mean even small demand can spark moves. Few short sellers remain; some may be trapped. 📌 Upcoming Catalysts & Compliance: • Quarterly filings updating DOGE holdings & crypto treasury • Capital raise or facility execution news • DOGE/BTC market action • SEC/corporate filings impacting liquidity 📈 Price Targets: • $3.50–$4.50 – initial gap fill • $6–$8+ – momentum extension • $12+ – speculative breakout Volume spikes, clean reclaim of $2.75, and low supply = explosive potential.

0 · Reply

GeeJoon Feb. 5 at 1:26 PM

$CANF 7 pipelines, 2 are really close to succeed, may copy the 8000% rocket fly like $DRUG

1 · Reply

Market Cap	831.91M
Revenue (ttm)	0.00
Net Income (ttm)	-8.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	109,628
Avg Vol	186,650
Day's Range	N/A - N/A
Shares Out	9.73M
Stochastic %K	84%
Beta	-6.18
Analysts	Strong Sell
Price Target	$131.60